Results 21 to 30 of about 3,923 (157)
A Multi‐Scale Computational Framework for Anti‐Persister Tuberculosis Drug Discovery
This review presents an integrated QSAR–scaffold design–docking–MD framework for discovering anti‐persister tuberculosis agents active in dormant granuloma‐like conditions. By targeting Mtb bioenergetics and prioritising dual NDH‐2/cytochrome bd oxidase inhibition, the workflow advances rational design of candidates with higher resistance barriers ...
Said Moshawih +6 more
wiley +1 more source
A literature review of QSPR approaches to predict jet fuel properties. It exposes the fundamental principles of QSPR and illustrates pure‐compound QSPR through examples of applications for jet fuel components. Mixture‐QSPR (M‐QSPR) modeling specificities are addressed: mixtures representation, design of descriptors for mixtures, and impact on internal ...
Erik Yeghyan +3 more
wiley +1 more source
On the Stability of CoMFA Models
Abrupt, smooth, and box methods for the calculation of electrostatic and steric field values in the comparative molecular field analysis (CoMFA) 3D QSAR technique are assessed on three diverse data sets of medicinal chemistry interest. While the standard
Jonathan D. Hirst (1937947) +1 more
core +1 more source
ABSTRACT Emancipation Day commemorates the end of slavery and is observed annually by African Guyanese on the first Monday in August. Celebrations provide a space to honor ancestors, express gratitude, mourn, and engage in cultural rejuvenation through communal activities such as night vigils, libation ceremonies, drumming, dancing, and pilgrimages to ...
Gillian Richards‐Greaves
wiley +1 more source
Improved CoMFA Modeling by Optimization of Settings
The possibility of improving the predictive ability of comparative molecular field analysis (CoMFA) by settings optimization has been evaluated to show that CoMFA predictive ability can be improved. Ten different CoMFA settings are evaluated, producing a
Shane D. Peterson (2653996) +2 more
core +1 more source
Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction
Structure–activity relationship of FMS‐like tyrosine kinase 3 (FLT3) as potent anti‐cancer agents supported by biological evaluation, in silico and clinical trial studies. ABSTRACT FMS‐like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase (RTK) important for hematopoietic stem cell proliferation, differentiation, and survival.
Ankush Kumar +4 more
wiley +1 more source
Enhancement of Ordinal CoMFA by Ridge Logistic Partial Least Squares
Conventional comparative molecular field analysis (CoMFA) requires at least 3 orders of experimental data, such as IC50 and Ki, to obtain a good model, although practically there are many screening assays where biological activity is measured only by ...
Kosuke Okamoto (2441500) +7 more
core +1 more source
Food Allergy Diagnosis in Early Childhood: Journey Mapping Study With Parents and Pediatricians
ABSTRACT Food allergy (FA) in early childhood can be challenging for families, even before a diagnosis is made, as parents often experience anxiety and have to change their routines. Research integrating parental and pediatrician perspectives during the pre‐diagnostic phase is scarce.
Madlen Hörold +3 more
wiley +1 more source
Decoding Urease Inhibition: A Comprehensive Review of Inhibitor Scaffolds
Representative functional groups known for urease inhibition are reviewed within diverse scaffolds using structure–activity analyses to identify features associated with high inhibitory activity. Urease is a metalloenzyme produced by a wide range of organisms and plays a critical role in nitrogen microbial metabolism by catalyzing the hydrolysis of ...
Nuno Martinho, Natália Aniceto
wiley +1 more source
Toward Integrative Predictive Toxicology: Advanced Methods for Drug Toxicity and Safety Prediction
This figure summarizes the different methods in integrative predictive toxicology reviewed in this work, ranging from exploration of molecular mechanisms to in silico pharmacokinetic modeling and construction of adverse outcome pathway (AOP) networks based on key events (KEs) and key event relationships (KERs). Further integration with multi‐omics data
Eleonora Gianquinto +6 more
wiley +1 more source

